Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Evaluating the Effect of Subanaesthetic Dose of Esketamine on Prevention of Postoperative Depression in Patients Undergoing Cardiac Surgery:a Randomized, Double-blind, Placebo-controlled Pilot and Feasibility Trial

To see complete record on, please visit this link

Id: NCT05155969

Organisation Name: Beijing Chao Yang Hospital

Overal Status: Recruiting

Start Date: December 1, 2021

Last Update: December 14, 2021

Lead Sponsor: Anshi Wu

Brief Summary: Esketamine is a general anesthetic with anti-depressant effects at subanaesthetic doses. This study hypothesized that intraoperative administration of ketamine would prevent or mitigate postoperative depressive symptoms in surgical patients.

  • Postoperative Depression

Total execution time in seconds: 0.27983784675598